Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Vaniqa Generic Name & Formulations
Legal Class
Rx
General Description
Eflornithine HCl 13.9%; crm.
Pharmacological Class
Hair growth retardant.
How Supplied
Crm—30g, 60g (2x30g)
Manufacturer
Vaniqa Indications
Indications
Reduction of unwanted facial hair in women.
Vaniqa Dosage and Administration
Adult
Apply a thin layer to affected areas of face and adjacent areas under the chin twice daily at least 8 hours apart; rub in thoroughly. Do not wash treated area for at least 4 hours. Continue to use hair removal techniques as needed. May apply cosmetics or sunscreens after cream dries.
Children
Not recommended.
Vaniqa Contraindications
Not Applicable
Vaniqa Boxed Warnings
Not Applicable
Vaniqa Warnings/Precautions
Warnings/Precautions
Reduce frequency if irritation or intolerance develops; discontinue if irritation continues. Abraded or broken skin. Pregnancy (Cat.C): not recommended. Nursing mothers.
Vaniqa Pharmacokinetics
Elimination
Renal. Half-life: ~8 hours.
Vaniqa Interactions
Not Applicable
Vaniqa Adverse Reactions
Adverse Reactions
Acne, pseudofolliculitis barbae, stinging, headache, burning, dry skin, erythema, tingling, dyspepsia, irritation, rash, alopecia, dizziness.
Vaniqa Clinical Trials
See Literature
Vaniqa Note
Not Applicable
Vaniqa Patient Counseling
See Literature
